Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 2, 1998

View Archived Issues

Abbott synthesizes a novel series of cyclic antifungal agents

Akzo Nobel describes new gonadotropins with therapeutic potential

Alcon discloses new antiglaucoma agents in patent literature

New antifungals from Lilly

New anticoagulants reported by Berlex

Canadian researchers design new cysteine protease inhibitors

Anti-MRSA agents prepared at Bristol-Myers Squibb

Warner-Lambert describes water-soluble, nonpeptide ET antagonists

New class of orally active bradykinin B2 antagonists presented by Fujisawa

Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity

Avakine submitted for FDA review

CIMA terminates one and initiates another OraSolv agreement

VX-740 advances in preclinical studies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...